Concepedia

Shawn Flanagan

SF

Statistics

Publications

11

Citations

509

H-Index

11

Active since

2002

Affiliations

University of Connecticut(Current)

Simulations Plus (United States)

Eli Lilly (United States)

Cidara Therapeutics (United States)

Pennsylvania State University

Shawn Flanagan is an author at University of Connecticut specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

2002–2025

11

Publications

11

Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

Mark Fineman, Shawn Flanagan, Kristin Taylor et al. · Clinical Pharmacokinetics · 2010 · 135 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Single‐ and Multiple‐Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid

Shawn Flanagan, Edward Fang, Kelly A. Muñoz et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2014 · 86 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Absorption, Distribution, Metabolism, and Excretion of the Novel Antibacterial Prodrug Tedizolid Phosphate

Voon Ong, Shawn Flanagan, Edward Fang et al. · Drug Metabolism and Disposition · 2014 · 77 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +15

Recovery From Injury in Sport: Considerations in the Transition From Medical Care to Performance Care

William J. Kraemer, Craig R. Denegar, Shawn Flanagan · Sports Health A Multidisciplinary Approach · 2009 · 59 citations

Medicine, Rehabilitation Medicine, Sports Medicine +17

Contributions of Saturable Active Secretion, Passive Transcellular, and Paracellular Diffusion to the Overall Transport of Furosemide Across Adenocarcinoma (Caco-2) Cells

Shawn Flanagan, Lpori H. Takahashi, Xiaoli Liu et al. · Journal of Pharmaceutical Sciences · 2002 · 39 citations

Engineering, Pharmacokinetics, Pharmacology +17

1–5 of 11